- Sun Pharmaceuticals recalls metformin after finding NDMA
Sun Pharmaceuticals has recalled one lot of its metformin pills after finding levels of N-Nitrosodimethylamine, or NDMA, a carcinogen, above the acceptable daily intake limit. - Acella recalls thyroid drug for subpotency
Acella Pharmaceuticals has recalled two lots of its thyroid drugs due to subpotency. - Becton Dickinson recalls Alaris infusion pump system for several hardware issues
Becton Dickinson has recalled its Alaris infusion pump system for a series of hardware issues that the FDA classified as Class I, the most serious type of recall, meaning use of the device could result in serious injury or death. - RLC labs recalls thyroid drug due to subpotency
RLC Labs, a drugmaker that focuses on drugs to treat hypothyroidism, recalled 483 lots of its Nature-Throid and WP Thyroid drugs after an FDA review found they were subpotent. - Mylan recalls 2 drugs after label mix-up
Mylan has recalled four lots of amiodarone HCl injection, which treats heart rhythm issues, and tranexamic acid injection, which promotes blood-clotting, after learning of a carton label mix-up. - Smiths Medical recalls syringe pumps due to risk of medication delivery error
Smiths Medical has recalled its Medfusion syringe pumps after finding a software issue may lead to over- or underdelivery of medication.
More articles on pharmacy:
FDA issues warning over TikTok ‘Benadryl challenge’
J&J says its COVID-19 vaccine spurred immune response in early study
Military personnel make up lion’s share of Operation Warp Speed leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.